The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

D. de Zeeuw; C. Arnott; J. -W. Li; C. P. Cannon; B. L. Neuen; H. J. L. Heerspink; B. Neal; D. M. Charytan; G. Bakris; T. -H. Chang; N. Rosenthal; B. Zinman; V. Perkovic; M. J. Jardine; K. W. Mahaffey

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

D. de Zeeuw, C. Arnott, J. -W. Li, C. P. Cannon, B. L. Neuen, H. J. L. Heerspink, B. Neal, D. M. Charytan, G. Bakris, T. -H. Chang, N. Rosenthal, B. Zinman, V. Perkovic, M. J. Jardine, K. W. Mahaffey

Onderzoeksoutput: Meeting Abstract › Academic

Originele taal-2	English
Pagina's (van-tot)	S61-S62
Aantal pagina's	2
Tijdschrift	Diabetologia
Volume	63
Nummer van het tijdschrift	SUPPL 1
Status	Published - sep.-2020
Evenement	56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) - Duur: 21-sep.-2020 → 25-sep.-2020

Handle.net

Permanente koppeling

Citeer dit

de Zeeuw, D., Arnott, C., Li, J. .-W., Cannon, C. P., Neuen, B. L., Heerspink, H. J. L., Neal, B., Charytan, D. M., Bakris, G., Chang, T. .-H., Rosenthal, N., Zinman, B., Perkovic, V., Jardine, M. J., & Mahaffey, K. W. (2020). The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial. Diabetologia, 63(SUPPL 1), S61-S62.

@article{e3a8b744ddab4befa740e5d8241f6229,

title = "The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial",

author = "{de Zeeuw}, D. and C. Arnott and Li, {J. -W.} and Cannon, {C. P.} and Neuen, {B. L.} and Heerspink, {H. J. L.} and B. Neal and Charytan, {D. M.} and G. Bakris and Chang, {T. -H.} and N. Rosenthal and B. Zinman and V. Perkovic and Jardine, {M. J.} and Mahaffey, {K. W.}",

year = "2020",

month = sep,

language = "English",

volume = "63",

pages = "S61--S62",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "SUPPL 1",

note = "56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) ; Conference date: 21-09-2020 Through 25-09-2020",

}

de Zeeuw, D, Arnott, C, Li, J-W, Cannon, CP, Neuen, BL, Heerspink, HJL, Neal, B, Charytan, DM, Bakris, G, Chang, T-H, Rosenthal, N, Zinman, B, Perkovic, V, Jardine, MJ & Mahaffey, KW 2020, 'The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial', Diabetologia, vol. 63, nr. SUPPL 1, blz. S61-S62.

TY - JOUR

T1 - The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics

T2 - 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD)

AU - de Zeeuw, D.

AU - Arnott, C.

AU - Li, J. -W.

AU - Cannon, C. P.

AU - Neuen, B. L.

AU - Heerspink, H. J. L.

AU - Neal, B.

AU - Charytan, D. M.

AU - Bakris, G.

AU - Chang, T. -H.

AU - Rosenthal, N.

AU - Zinman, B.

AU - Perkovic, V.

AU - Jardine, M. J.

AU - Mahaffey, K. W.

PY - 2020/9

Y1 - 2020/9

M3 - Meeting Abstract

SN - 0012-186X

VL - 63

SP - S61-S62

JO - Diabetologia

JF - Diabetologia

IS - SUPPL 1

Y2 - 21 September 2020 through 25 September 2020

ER -